{
  "title": "Acute Radiation Syndrome",
  "category": "Radiation Oncology",
  "section": "Acute Toxicities",
  "summary": "Acute radiation syndrome (ARS) occurs following high-dose whole-body or significant partial-body irradiation, characterized by prodromal, latent, manifest illness, and recovery phases with distinct clinical presentations.",
  "content": [
    {
      "type": "heading",
      "level": 2,
      "text": "Pathophysiology"
    },
    {
      "type": "paragraph",
      "text": "ARS results from radiation damage to rapidly dividing cell populations, particularly hematopoietic, gastrointestinal, and neurovascular systems. The severity depends on dose, dose rate, and extent of body exposure."
    },
    {
      "type": "heading",
      "level": 2,
      "text": "Clinical Phases"
    },
    {
      "type": "paragraph",
      "text": "Prodromal phase (0-48 hours): nausea, vomiting, diarrhea, fatigue. Latent phase (48 hours-weeks): apparent recovery. Manifest illness phase: bone marrow, GI, or neurovascular syndrome. Recovery phase: gradual improvement or death."
    },
    {
      "type": "heading",
      "level": 2,
      "text": "Dose-Response Relationships"
    },
    {
      "type": "paragraph",
      "text": "Hematopoietic syndrome (1-10 Gy): lymphopenia, thrombocytopenia, anemia. GI syndrome (10-50 Gy): severe diarrhea, dehydration, infection. Neurovascular syndrome (>50 Gy): altered consciousness, seizures, death within days."
    },
    {
      "type": "clinical_pearl",
      "text": "Lymphocyte count depression within 48 hours is the most reliable early indicator of significant radiation exposure and dose estimation."
    }
  ]
}
